PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Accordingly, there is a need for a method of treatment forglaucoma or for lowering intraocular pressure utilizing beta-blocking agents which are relatively free of unwanted systemic side-effects.Certain beta-blocking agents which contain enzymatically labile ester groups are known to exhibit short-acting beta-blocking effects in the systemic circulation.
http://www.w3.org/ns/prov#wasQuotedFrom
  • patentgenius.com